Posted by Editor | Posted in Defective Drugs
Anti-psychotic drugs that are commonly prescribed to Alzheimer’s patients to control hallucinations and calm aggression may actually increase the patient’s chance of dying within a few years, says a new study published Friday in the Lancet Neurology medical journal.
”For the vast majority of Alzheimer’s patients, taking these drugs is probably not a worthwhile risk,” Clive Ballard, the paper’s lead author told The New York Times.
”Would I want to take a drug that slightly reduced my aggression but doubled my risk of dying? I’m not sure I would,” Ballard continued.
The research was published Friday in the medical journal, Lancet Neurology
Get information about defective drugs and filing a defective drug lawsuit.










